Stoke Therapeutics STOK
NASDAQ STOK
$26.01 +0.01 (+0.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) EV to FCF (2025)

Updated

Stoke Therapeutics' EV to FCF came in at 35.30 for Q4 2025, up 76.6% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) EV to FCF (2025) Analysis & Trends

Going back to Q1 2025, Stoke Therapeutics' EV to FCF data covers 4 quarters.

  • Business Quant data shows STOK's EV to FCF at 19.99 (Q3 2025), 6.11 (Q2 2025) and 0.08 (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 35.30
Sep 30, 2025 19.99
Jun 30, 2025 6.11
Mar 31, 2025 0.08
API Access

Stoke Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=STOK&period=max&api_key=YOUR_API_KEY